26 results
Keyword paxlovid Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Comirnaty (updated)
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020,
, 
, Revision: 41, Authorised, Last updated: 24/03/2023
-
List item
Human medicine European public assessment report (EPAR): Paxlovid (updated)
nirmatrelvir, ritonavir, COVID-19 virus infection
Date of authorisation: 28/01/2022, Revision: 10, Authorised, Last updated: 07/03/2023Paxlovid Pneumonia, Viral Respiratory … Paxlovid … EMA/80728/2023 EMEA/H/C/005973 Paxlovid (PF-07321332 / ritonavir … -
List item
Human medicine European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna)
CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021,, , Revision: 35, Authorised, Last updated: 21/02/2023
-
List item
Human medicine European public assessment report (EPAR): COVID-19 Vaccine (inactivated, adjuvanted) Valneva
SARS-CoV-2 virus (inactivated) Wuhan strain hCoV-19 / Italy / INMI1-isl / 2020, COVID-19 virus infection
Date of authorisation: 24/06/2022,, Revision: 5, Authorised, Last updated: 17/02/2023
-
List item
Human medicine European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen)
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S), COVID-19 virus infection
Date of authorisation: 11/03/2021,, , Revision: 28, Authorised, Last updated: 17/02/2023
-
List item
Human medicine European public assessment report (EPAR): Nuvaxovid
SARS-CoV-2 recombinant spike protein, COVID-19 virus infection
Date of authorisation: 20/12/2021,, 
, Revision: 7, Authorised, Last updated: 10/01/2023
-
List item
News: ETF warns that monoclonal antibodies may not be effective against emerging strains of SARS-CoV-2
Last updated: 09/12/2022Antiviral treatments such as Paxlovid (nirmatrelvir / ritonavir … treating COVID-19, including Paxlovid and Veklury, is available … Nirmatrelvir/Ritonavir (Paxlovid)15 and Remdesivir (Veklury)16 … -
List item
Human medicine European public assessment report (EPAR): VidPrevtyn Beta
SARS-CoV-2 prefusion Spike delta TM protein, recombinant (B.1.351 strain), COVID-19 virus infection
Date of authorisation: 10/11/2022,, Authorised, Last updated: 30/11/2022
-
List item
Human medicine European public assessment report (EPAR): Evusheld
tixagevimab, cilgavimab, COVID-19 virus infection
Date of authorisation: 25/03/2022,, Revision: 1, Authorised, Last updated: 16/11/2022
-
List item
COVID-19: latest updates
Last updated: 31/10/2022marketing authorisation for Paxlovid to standard The approval to … States. marketing authorisation Paxlovid 26/01/2023 COVID-19 treatments … information for COVID-19 treatment Paxlovid, with an increase in its approved …
-
List item
COVID-19 treatments: authorised
Last updated: 12/08/2022granted: 17/12/2021 Latest news Paxlovid (PF-07321332 / ritonavir …
-
List item
COVID-19 treatments: Article 18 and Article 5(3) reviews
Last updated: 27/07/2022Treatment Status More information Paxlovid (PF-07321332 / ritonavir … EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir …
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 January 2022
CHMP, Last updated: 05/07/2022Paxlovid … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2022
PRAC, Last updated: 10/06/2022 -
List item
Availability of medicines during COVID-19 pandemic
Last updated: 08/06/2022 -
List item
News: EMA adopts first list of critical medicines for COVID-19
Last updated: 08/06/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022marketing authorisation for Paxlovid … marketing authorisation for Paxlovid … THE MEDICINAL PRODUCT Paxlovid 150 mg + 100 mg film-coated … -
List item
News: EMA receives application for conditional marketing authorisation for Paxlovid (PF-07321332 and ritonavir) for treating patients with COVID-19
CHMP, PRAC, Last updated: 10/01/2022marketing authorisation for Paxlovid (PF-07321332 and ritonavir … marketing authorisation for Paxlovid (PF-07321332 and ritonavir … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 December 2021
CHMP, Last updated: 17/12/2021COVID-19: Advice on use of Paxlovid for treating COVID-19 The … -
List item
News: EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir) for the treatment of COVID-19: rolling review starts in parallel
CHMP, Last updated: 16/12/2021EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir … EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir … -
List item
Public stakeholder meeting on COVID-19 vaccines and therapeutics in the EU
Online, 13:00 - 15:15 Amsterdam time (CET), 25/11/2021, Last updated: 25/11/2021 -
List item
News: EMA starts review of Paxlovid for treating patients with COVID-19
CHMP, Last updated: 19/11/2021EMA starts review of Paxlovid for treating patients with … EMA starts review of Paxlovid for treating patients with … -
List item
Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 19 November 2021
Online, 19/11/2021, Last updated: 25/10/2021Lagevrio (molnupiravir) and Paxlovid (PF-07321332 / ritonavir … (19/11/2021) EMA starts review of Paxlovid for treating patients with … -
List item
COVID-19 treatments
Last updated: 14/10/2021Paxlovid …
-
List item
Public-health advice during COVID-19 pandemic
Last updated: 27/05/2021Nirmatrelvir/Ritonavir (Paxlovid)15 and Remdesivir (Veklury)16 …